Combined Use of a Solid-Phase Hexapeptide Ligand Library with Liquid Chromatography and Two-Dimensional Difference Gel Electrophoresis for Intact Plasma Proteomics
Figure 4
Localization of protein spots showing different intensities between the ProteoMinor-treated and untreated samples. Panels (a–k) correspond to those in Figure 3. The protein spot numbers corresponds to those in Supplementary Tables 5 and 6. −/−: number of protein spots without ProteoMiner treatment/those with ProteoMiner treatment.